ELUCIDATING THE MECHANISM OF RECEPTOR TYROSINE KINASE INHIBITION BY SOLUBLE LRIG1 IN GLIOBLASTOMA

被引：0
|
作者：
Tiemann, Katja [1 ]
Hedman, Hakan [2 ]
Niclou, Simone P. [1 ]
机构：
[1] CRP Sante, NorLux Neurooncol Lab, Dept Oncol, Luxembourg, Luxembourg
[2] Umea Univ, Dept Radiat Sci, Umea, Sweden
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [41] Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
    Marcus Thomasson
    Håkan Hedman
    Börje Ljungberg
    Roger Henriksson
    BMC Research Notes, 5 (1)
  • [42] TYROSINE KINASE RECEPTOR SIGNALING IN GLIOBLASTOMA CELLS: THERAPEUTIC IMPLICATIONS
    Alexandru, O.
    Carapancea, M.
    Fetea, A.
    Dragutescu, L.
    Castro, J.
    Georgescu, A. M.
    Backlund, M. L.
    Dricu, A.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1113 - 1113
  • [43] Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
    Snuderl, Matija
    Fazlollahi, Ladan
    Le, Long P.
    Nitta, Mai
    Zhelyazkova, Boryana H.
    Davidson, Christian J.
    Akhavanfard, Sara
    Cahil, Daniel P.
    Aldape, Kenneth D.
    Betensky, Rebecca A.
    Louis, David N.
    Iafrate, A. John
    CANCER CELL, 2011, 20 (06) : 810 - 817
  • [44] DIFFERENTLY SPLICED CDNAS OF HUMAN-LEUKOCYTE TYROSINE KINASE RECEPTOR TYROSINE KINASE PREDICT RECEPTOR PROTEINS WITH AND WITHOUT A TYROSINE KINASE DOMAIN AND A SOLUBLE RECEPTOR PROTEIN
    TOYOSHIMA, H
    KOZUTSUMI, H
    MARU, Y
    HAGIWARA, K
    FURUYA, A
    MIOH, H
    HANAI, N
    TAKAKU, F
    YAZAKI, Y
    HIRAI, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5404 - 5408
  • [45] A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
    S Goldoni
    R A Iozzo
    P Kay
    S Campbell
    A McQuillan
    C Agnew
    J-X Zhu
    D R Keene
    C C Reed
    R V Iozzo
    Oncogene, 2007, 26 : 368 - 381
  • [46] Tyrosine kinase inhibition affects type 1 angiotensin II receptor internalization
    Becker, BN
    Kondo, S
    Chen, JK
    Harris, RC
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (06): : 975 - 993
  • [47] Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain - Comment
    Rutka, JT
    NEUROSURGERY, 1997, 40 (01) : 151 - 151
  • [48] Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
    Qiuhui Li
    Bigang Liu
    Hsueh-Ping Chao
    Yibing Ji
    Yue Lu
    Rashid Mehmood
    Collene Jeter
    Taiping Chen
    John R. Moore
    Wenqian Li
    Can Liu
    Kiera Rycaj
    Amanda Tracz
    Jason Kirk
    Tammy Calhoun-Davis
    Jie Xiong
    Qu Deng
    Jiaoti Huang
    Barbara A. Foster
    Abhiram Gokhale
    Xin Chen
    Dean G. Tang
    Nature Communications, 11
  • [49] Inhibition of the insulin receptor tyrosine kinase by phosphatidic acid
    Arnold, RS
    Newton, AC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (04) : 516 - 528
  • [50] INHIBITION OF THE INSULIN-RECEPTOR TYROSINE KINASE BY SPHINGOSINE
    ARNOLD, RS
    NEWTON, AC
    BIOCHEMISTRY, 1991, 30 (31) : 7747 - 7754
12345